Oxford textbook of medicine /
Mention d'édition :5th ed. Publié par : Oxford University Press, (Oxford :) Détails physiques : 3 volumes (li, 5518, 110 pages) : illustrations (some color) ; 28 cm ISBN :9780199204854; 0199204853; 9780199592852; 0199592853; 9780199592869; 0199592861; 9780199592876; 019959287X. Année : 2010Type de document | Site actuel | Cote | Statut | Date de retour prévue | Code à barres | Réservations |
---|---|---|---|---|---|---|
Livre | La bibliothèque des Sciences Médicales et Pharmaceutiques | 616 WAR VOL.1 (Parcourir l'étagère) | Disponible | 0000000027387 | ||
Livre | La bibliothèque des Sciences Médicales et Pharmaceutiques | 616 WAR VOL.3 (Parcourir l'étagère) | Disponible | 0000000019293 | ||
Livre | La bibliothèque des Sciences Médicales et Pharmaceutiques | 616 WAR VOL.2 (Parcourir l'étagère) | Disponible | 0000000021074 |
Includes bibliographical references and index.
v. 1. Sections 1-12 -- v. 2. Sections 13-19 -- v. 3. Sections 20-33.
Radioisotope-based molecular imaging probes provide unprecedented insight into biochemistry and function involved in both normal and disease states of living systems, with unbiased in vivo measurement of regional radiotracer activities offering very high specificity and sensitivity. No other molecular imaging technology including functional magnetic resonance imaging (fMRI) can provide such high sensitivity and specificity at a tracer level. The applications of this technology can be very broad ranging from drug development, pharmacokinetics, clinical investigations, and finally to routine diagnostics in radiology. The design and the development of radiopharmaceuticals for molecular imaging studies using PET/MicroPET or SPECT/MicroSPECT are a unique challenge. This book is intended for a broad audience and written with the main purpose of educating the reader on various aspects including potential clinical utility, limitations of drug development, and regulatory compliance and approvals.
Il n'y a pas de commentaire pour ce document.